Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects:

Overall cooperation that occurs in networks gradually increases as <i>τ</i> is increased in networks. by Adam Lee Miles (14123916)

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

“…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”

The relative duration and distance in each time gap. by Tomohiro Gonjo (8825780)

Increasing gaps and decreasing returns attenuate spending effects. by William Minozzi (8564712)

Group C example; CXCL6: Temporal pattern of protein expression level (mean NPX ± 0.95 CI) for C-X-C motif chemokine ligand 6 (CXCL6) showing statistically significant late peak and... by Pavlos Vlachogiannis (12289810)

Mean±SD of BTT and threshold in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Gradual increase in EEG theta power and histopathological changes in RML. by Lech Kaczmarczyk (587512)

Mean concentrations of sum monoterpenes and single monoterpenes: α-pinene, β-pinene, myrcene, limonene, β-(E)-ocimene, and α-terpineol obtained from the 10 distillation time (DT) f... by Valtcho D. Zheljazkov (627617)

Mean concentrations of sum cannabinoids, CBD, Cannabichromene, δ8-Tetrahydrocannabinol, δ9-Tetrahydrocannabinol, and other EO constituents (acid asters, ketone, alcohol) obtained f... by Valtcho D. Zheljazkov (627617)

Mean, SD, and Pearson correlations between SWB scales scores. by August Håkan Nilsson (12937056)

Subjects:

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... by Mingee Choi (15250732)

Subjects:

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

Subjects:

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects:

General information of patient who diagnosis insomnia disorder (N = 518,119). by Mingee Choi (15250732)

Subjects:

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. by Mingee Choi (15250732)

Subjects:

Treatment at first diagnosis of insomnia disorder (%). by Mingee Choi (15250732)

Subjects:

Mean trace metal levels over the study period. by Caroline Fortmann (4510228)

Subjects:

Change in Mean Anxiety Scores Over time by group. by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. There was an overall decrease in State Trait Anxiety Inventory (STAI) scores of participants after counseling (p = 0.002) but no statistically difference in change of STAI scores between the two groups (p = 0.981).…”

<i>SOX2</i> knockdown decreases OSCC cell migration and EMT. by Alessandro Sacco (8799386)